ACCD Accolade

Accolade To Present at Upcoming Investor Conferences

Accolade To Present at Upcoming Investor Conferences

SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor conferences:

  • Raymond James 45th Annual Institutional Investors Conference in Orlando on Tuesday, March 5 at 8:05 am ET
  • Barclays 26th Annual Global Healthcare Conference in Miami Beach on Wednesday, March 13 at 1:35 pm ET

A webcast of these events will be available at ir.accolade.com and a replay will be available for 90 days.

About Accolade, Inc.

Accolade (Nasdaq: ACCD) is a Personalized Healthcare company that provides millions of people and their families with exceptional healthcare experiences so they can live their healthiest lives. Accolade’s employer, health plan, and consumer solutions combine virtual primary care and mental health, expert medical opinion, and best-in-class care navigation. These offerings are built on a platform that is engineered to care through predictive engagement of population health needs, proactive care that improves outcomes and cost savings, and by addressing barriers to access and continuity of care. Accolade consistently receives consumer satisfaction ratings of over 90%. For more information, visit . Follow us on ,   and .

Investor Contact:

Todd Friedman, Investor Relations,

Source: Accolade



EN
28/02/2024

Underlying

ACCDAccolade

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Accolade

 PRESS RELEASE
Free
ACCD ACCOLADE

Accolade Announces Results for Fiscal Fourth Quarter and Full Year 202...

Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024 SEATTLE, April 25, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal fourth quarter and full year ended February 29, 2024. "Accolade has built a rare healthcare services business at scale with consistently strong growth rates. Whether serving consumers, employers, health plans, or government entities, the core of our value proposition is making healthcare easier to access, navigate, and consume for our members. We provide a unique blend of healthcare services and ...

April 25, 2024 1 EN
 PRESS RELEASE
Free
ACCD ACCOLADE

Accolade to Announce Fiscal Fourth Quarter 2024 Financial Results

Accolade to Announce Fiscal Fourth Quarter 2024 Financial Results SEATTLE, April 03, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal fourth quarter 2024 financial results on Thursday, April 25, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call Details To Listen via Telephone: Pre-registration is required by the conference call operator. Please pre-register by clicking . () Upon registering, you will be emailed a dial-in numb...

April 3, 2024 1 EN
 PRESS RELEASE
Free
ACCD ACCOLADE

Accolade To Present at Upcoming Investor Conferences

Accolade To Present at Upcoming Investor Conferences SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor conferences: Raymond James 45th Annual Institutional Investors Conference in Orlando on Tuesday, March 5 at 8:05 am ETBarclays 26th Annual Global Healthcare Conference in Miami Beach on Wednesday, March 13 at 1:35 pm ET A webcast of these events will be available at ir.accolade.com and a replay will be available for 90 days. About Accolade, Inc. Accolade (Nasdaq: ACCD) is a Personaliz...

February 28, 2024 1 EN
 PRESS RELEASE
Free
ACCD ACCOLADE

Accolade Announces Results for Fiscal Third Quarter 2024

Accolade Announces Results for Fiscal Third Quarter 2024 SEATTLE, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal third quarter ended November 30, 2023. “As we head into the new year, Accolade continues to define the future of how healthcare should be experienced in this country. Our unique combination of people and technology is creating a new model for improving health outcomes and helping our more than 10 million members live healthier lives. We are closing the physician gap, improving access to care, and leveraging AI a...

January 8, 2024 1 EN
 PRESS RELEASE
Free
ACCD ACCOLADE

Accolade To Present at Upcoming Investor Conferences

Accolade To Present at Upcoming Investor Conferences SEATTLE, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor conferences: 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 11 at 7:30am PT26th Annual Needham Growth Conference in New York on Thursday, January 18 at 3:00pm ET A webcast of these events will be available at ir.accolade.com and a replay will be available for 90 days. About Accolade, Inc. Accolade (Nasdaq: ACCD) is a Personalized Healthcare company...

January 2, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch